Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
VIVIMEDLAB
₹5.40
₹5.40
₹5.68
₹5.15
₹29.40
Markets Today
Historical Performance
As of 10-07-2026 22:20, Vivimed Labs Ltd. share price today is ₹0, with a change of ₹-5.41 (-100.00%) from the previous close of ₹5.41. The stock opened at ₹5.41 and traded between ₹5.4 and ₹5.68, with a total traded volume of 66424 shares. The company has a market capitalization of ₹44.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹29.4 and ₹5.15, respectively.
Vivimed Labs Ltd. valuation metrics include a P/E ratio of -1.3, EPS of ₹-3.85, and book value of ₹-0.60. Vivimed Labs Ltd. has reported revenue of ₹83.6 Cr and net profit of ₹-34.95 Cr.
Vivimed Labs Ltd. technical indicators include Day RSI at 31.29, Day MFI at 32.19, Day ADX at 35.96. Additional indicators include Commodity Channel Index (CCI) at -170.1 and Williams %R at -89.36. Momentum indicators show Day MACD at -0.22, Day MACD Signal Line at -0.2, DayATR at 0.35. Rate of Change indicators for Vivimed Labs Ltd. include ROC125 at -64.22 and ROC21 at -12.03.
Exponential moving averages include EMA5 at ₹5.5, EMA10 at ₹5.6, EMA12 at ₹5.7, EMA20 at ₹5.8, EMA26 at ₹5.9, EMA50 at ₹6.2, EMA100 at ₹6.9, EMA200 at ₹8.2. Simple moving averages include SMA5 at ₹5.6, SMA10 at ₹5.7, SMA20 at ₹5.9, SMA30 at ₹6, SMA50 at ₹6.3, SMA100 at ₹6.6, SMA150 at ₹7.9, SMA200 at ₹8.5.
Support levels for Vivimed Labs are placed at First Support ₹5.28, Second Support ₹5.16, Third Support ₹5.00. Resistance levels are seen at First Resistance ₹5.56, Second Resistance ₹5.72, Third Resistance ₹5.84. Vivimed Labs Ltd. shareholding pattern shows promoter holding at 7.57%, FII holding at 1.64%, DII holding at 0%, public holding at 90.66%.
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 11.63 | 18.66 | 17.94 | 22.58 | 34.23 |
| Operating Expense | 22.85 | 19.98 | 18.48 | 25.06 | 34.41 |
| Operating Profit | -11.22 | -1.32 | -0.54 | -2.48 | -0.18 |
| Depreciation | 4.40 | 4.68 | 4.80 | 4.61 | 6.37 |
| Interest | 0.94 | 1.60 | 0.52 | 1.48 | 0.43 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -16.57 | -7.44 | -5.50 | -4.42 | -6.97 |
₹5.40
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 20.9 | 20.9 | 7.8 | 7.8 | 7.8 | 7.6 |
| FII | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| DII | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Public | 77.3 | 77.3 | 90.5 | 90.5 | 90.5 | 90.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 88.46 K | 88.46 K | 100.00% |
| Week | 93.48 K | 93.48 K | 100.00% |
| 1 Month | 1.02 L | 1.02 L | 100.00% |
| 6 Month | 2.39 L | 3.1 L | 77.04% |
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2018 | 0.4 | FINAL | Equity Share | |
| 21 Sep, 2017 | 0.4 | FINAL | Equity Share | |
| 24 Sep, 2014 | 3 | FINAL | Equity Share | |
| 24 Sep, 2013 | 3 | FINAL | Equity Share | |
| 21 Sep, 2012 | 3 | FINAL | Equity Share | |
| 26 Sep, 2011 | 2 | FINAL | Equity Share | |
| 09 Sep, 2010 | 1.5 | FINAL | Equity Share | |
| 24 Sep, 2009 | 1.5 | FINAL | Equity Share | |
| 22 Sep, 2008 | 1 | FINAL | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹179.17 | ₹15.60 | ₹535 | ₹62 |
| % Change | -1.43% | -2.00% | 0.84% | -0.10% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | 47.70 | 29.60 | 26.70 | -103.00 |
| 1 Year Return | 52.07 | 45.1 | 70 | -25.38 | -41.91 |
| ROCE | 3.56 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Bajaj Healthcare Ltd.
₹ 345.50
-1.31%
Ortin Global Ltd.
₹ 16.50
+1.10%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
RPG Life Sciences Ltd.
₹ 2861.10
+7.69%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy